文献速递细菌感染、耐药与抗菌药物

台湾B群链球菌左氧氟沙星耐药的多克隆涌现

Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
PubMed 文献 · J Antimicrob Chemother · 2017-01-01

该研究分析了2002至2012年台湾全国监测中1559株B群链球菌,发现左氧氟沙星耐药率从2.2%升至6.2%(P=0.016),88株耐药株以GyrA(S81L)+ParC(S79F/Y)双突变为主(79.5%),主要基因型为ST19/血清III型(43.2%),并发现新基因型ST1及其单基因变异株/血清VI型(28.4%)和ST1/血清II型(18.2%)在局部流行。老年和呼吸道标本为左氧氟沙星耐药的独立相关因素。

要点

  • 左氧氟沙星耐药率从2002-06年的2.2%上升至2008-12年的6.2%(P=0.016)。
  • 耐药株多数(79.5%)携带GyrA(S81L)+ParC(S79F/Y)双突变。
  • 老年和呼吸道标本是左氧氟沙星耐药的独立相关因素。

核心结论

  • 台湾医疗和社区环境中出现了左氧氟沙星耐药B群链球菌的多克隆涌现和播散。
  • 持续分子水平监测对发现新流行趋势很重要。

研究设计与样本

  • 2002至2012年每两年从多家医院收集所有样本类型和患者群体的B群链球菌临床分离株,共1559株。
  • 采用肉汤微量稀释法测定抗菌药物敏感性,并对左氧氟沙星耐药株进行血清分型、PFGE、QRDR突变和MLST分子研究。

主要发现

  • 所有1559株分离株对青霉素、头孢菌素、美罗培南和万古霉素敏感。
  • 左氧氟沙星耐药率从2002-06年的2.2%(范围0%-3.3%)上升至2008-12年的6.2%(5.9%-7.5%),P=0.016。
  • 88株左氧氟沙星耐药株中,79.5%有GyrA(S81L)+ParC(S79F/Y)双突变,54.5%同时对克林霉素、红霉素和四环素耐药。
  • 耐药株主要基因型为ST19/血清III型(43.2%),新发现基因型ST1及其单基因变异株(ST920和ST922)/血清VI型(28.4%)和ST1/血清II型(18.2%)在局部流行。
  • 血清III型分离株主要来自尿液和女性生殖道标本及<65岁成人门诊患者,血清II和VI型主要来自呼吸道和尿液标本及>65岁住院患者。

关键数值与推荐

  • 左氧氟沙星耐药率从2002-06年的2.2%(范围0%-3.3%)上升至2008-12年的6.2%(5.9%-7.5%),P=0.016。
  • 88株左氧氟沙星耐药株中79.5%有GyrA(S81L)+ParC(S79F/Y)双突变,54.5%同时对克林霉素、红霉素和四环素耐药。
  • 左氧氟沙星耐药株主要基因型为ST19/血清III型(43.2%),新基因型ST1及其单基因变异株/血清VI型(28.4%)和ST1/血清II型(18.2%)在局部流行。
  • 多因素分析显示老年和呼吸道标本是左氧氟沙星耐药的独立相关因素。

临床怎么用

  • 在台湾地区,尤其对老年和呼吸道标本来源的B群链球菌感染,应关注左氧氟沙星耐药可能。
  • 持续分子水平监测有助于发现新流行克隆和耐药趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study investigated the trend in antimicrobial resistance among group B Streptococcus (GBS) from a national surveillance programme in Taiwan and delineated characteristics of and factors associated with levofloxacin-resistant isolates. METHODS: Clinical isolates of all sample types and patient groups were collected from multiple hospitals biennially between 2002 and 2012. Susceptibilities to different antibiotics were determined by broth microdilution. Molecular studies of levofloxacin-resistant isolates included serotyping, PFGE, mutations in the QRDRs and MLST. RESULTS: A total of 1559 isolates were tested and all remained susceptible to penicillin, cephalosporins, meropenem and vancomycin. However, levofloxacin resistance increased from 2.2% (range 0%-3.3%) in 2002-06 to 6.2% (5.9%-7.5%) in 2008-12 (P = 0.016). Among the 88 levofloxacin-resistant isolates, the majority (79.5%) had the GyrA(S81L)+ParC(S79F/Y) double mutations and most (54.5%) were also resistant to clindamycin, erythromycin and tetracycline. The predominant genotype of the levofloxacin-resistant isolates was ST19/serotype III (43.2%). Four previously unreported genotypes, ST1 and its single-locus variants (ST920 and ST922)/serotype VI (28.4%) and ST1/serotype II (18.2%), were found to have circulated locally. Serotype III isolates were predominately from urine and female genital tract specimens and <65-year-old adult outpatients, while serotype II and VI isolates were mostly from respiratory and urine samples and >65-year-old inpatients. Multivariate analysis revealed that elderly age and respiratory samples were independent factors associated with levofloxacin resistance. CONCLUSIONS: Multiclonal emergence and dissemination of levofloxacin-resistant GBS isolates occurred in healthcare and community settings in Taiwan. Continuous molecular-level surveillance is important to detect new epidemic trends.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Wu CJ, Lai JF, Huang IW, et al. Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan. J Antimicrob Chemother. 2017. PMID: 28961888. doi:10.1093/jac/dkx297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。